Filing Details

Accession Number:
0001181431-15-001523
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-27 19:52:31
Reporting Period:
2015-01-23
Filing Date:
2015-01-27
Accepted Time:
2015-01-27 19:52:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
927066 Davita Healthcare Partners Inc. DVA Services-Misc Health & Allied Services, Nec (8090) 510354549
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604063 David Michael Staffieri C/O Davita Healthcare Partners Inc.
2000 16Th Street
Denver CO 80202
Coo, Kidney Care No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-23 40,000 $34.52 40,394 No 4 M Direct
Common Stock Disposition 2015-01-23 18,131 $76.15 22,263 No 4 F Direct
Common Stock Disposition 2015-01-23 21,869 $76.05 394 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2015-01-23 40,000 $0.00 40,000 $34.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-09-30 2015-09-30 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2014.
  2. Represents the weighted average sale price of $76.0542. The range of prices for the sale of these shares was $75.76 - $76.26, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
  3. Includes 394 shares that were purchased through the 2014 Employee Stock Purchase Program (ESPP)on 12/31/2014.
  4. Stock Appreciation Rights, granted on 9/30/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.